The effects of chitosan/miR-200c nanoplexes on different stages of cancers in breast cancer cell lines

Eur J Pharm Sci. 2016 Dec 1:95:103-110. doi: 10.1016/j.ejps.2016.05.030. Epub 2016 May 31.

Authors

Kubra Kaban¹, Emine Salva², Julide Akbuga³

Affiliations

¹ Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Marmara University, Tıbbiye Street, 34668 Istanbul, Turkey.
² Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Inonu University, Central Campus, 44280 Malatya, Turkey.
³ Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Marmara University, Tıbbiye Street, 34668 Istanbul, Turkey. Electronic address: jakbuga@marmara.edu.tr.

PMID: 27260087
DOI: 10.1016/j.ejps.2016.05.030

No abstract available

Keywords: Breast cancer; Chitosan; miR-200c; miRNA delivery system.

MeSH terms

Apoptosis / drug effects*
Apoptosis / physiology
Breast Neoplasms* / drug therapy
Breast Neoplasms* / metabolism
Chitosan / administration & dosage*
Chitosan / chemistry
Chitosan / metabolism
Drug Carriers / administration & dosage
Drug Carriers / chemistry
Female
Humans
MCF-7 Cells
MicroRNAs / administration & dosage*
MicroRNAs / chemistry
MicroRNAs / metabolism
Neoplasm Staging / methods
Treatment Outcome

Substances

Drug Carriers
MIRN200 microRNA, human
MicroRNAs
Chitosan